Citations

Showing 10 of 108152 citations.

Understanding the effect of categorization of a continuous predictor with application to neuro-oncology
Gupta, R. , Day, Courtney N. , Tobin, W. Oliver , Crowson, Cynthia S. , Gupta, Ruchi , Tobin, Wlliam O, Tobin, W Oliver , Gupta, Ruchi

Mayo Clinic

Neuro-Oncology Practice | August 4, 2021 | Volume: 9 | Issue: 2 | Pages: 87-90

10.1093/nop/npab049 | PMID 35371519 Get It

Abstract Many neuro-oncology studies commonly assess the association between a prognostic factor (predictor) and disease or outcome, such as the association between age and glioma. Predictors can be continuous (eg, age) or categorical (eg, race/ethnicity). Effects of categorical predictors are frequently easier to visualize and interpret than effects of continuous variables. This makes it an attractive, and seemingly justifiable, option to subdivide the continuous predictors into categories (eg, age <50 years vs age ≥50 years). However, this approach results in loss of information (and power) compared to the continuous version. This review outlines the use cases for continuous and categorized predictors and provides tips and pitfalls for interpretation of these approaches.
Extensive heterogeneity of glycopeptides in plasma revealed by deep glycoproteomic analysis using size-exclusion chromatography
Saraswat, Mayank , Garapati, Kishore , Pandey, Akhilesh , Pandey, Akhilesh , Garapati, Kishore , Mun, Dong‐Gi

Mayo Clinic

Molecular Omics | August 4, 2021 | Volume: 17 | Issue: 6 | Pages: 939-947

10.1039/d1mo00132a | PMID 34368825 Get It

Abstract Several plasma glycoproteins are clinically useful as biomarkers in a variety of diseases. Although thousands of proteins are present in plasma, >95% of the plasma proteome by mass is represented by only 22 proteins. This necessitates strategies to deplete the abundant proteins and enrich other subsets of proteins. Although glycoproteins are abundant in plasma, in routine proteomic analyses, glycopeptides are not often investigated. Traditional methods such as lectin-based enrichment of glycopeptides followed by deglycosylation have helped understand the glycoproteome, but they lack any information about the attached glycans. Here, we apply size-exclusion chromatography (SEC) as a simple strategy to enrich intact N-glycopeptides based on their larger size which achieves broad selectivity regardless of the nature of attached glycans. Using this approach, we identified 1317 N-glycopeptides derived from 266 glycosylation sites on 154 plasma glycoproteins. The deep coverage achieved by this approach was evidenced by extensive heterogeneity that was observed. For instance, 20–100 glycopeptides were observed per protein for the 15 most-glycosylated glycoproteins. Notably, we discovered 615 novel glycopeptides of which 39 glycosylation sites (from 38 glycoproteins) were not included in protein databases such as Uniprot and GlyConnectDB. Finally, we also identified 12 novel glycopeptides containing di-sialic acid, which is a rare glycan epitope. Our results demonstrate the utility of SEC for efficient LC-MS/MS-based deep glycoproteomics analysis of human plasma. Overall, the SEC-based method described here is a simple, rapid and high-throughput strategy for characterization of any glycoproteome.
COVLIAS 1.0: Lung Segmentation in COVID-19 Computed Tomography Scans Using Hybrid Deep Learning Artificial Intelligence Models
Suri, Jasjit S. , Agarwal, Sushant , Ketireddy, Vedmanvitha, Columbu, Marta, Saba, Luca , Gupta, Suneet Kumar , Singh, Inder M. , Turk, Monika, Chadha, Paramjit S., Johri, Amer M. , Khanna, Narendra N. , Višković, Klaudija , Laird, John R. , Pareek, Gyan , Miner, Martin , Sobel, David , Balestrieri, Antonella , Sfikakis, Petros P. , Tsoulfas, George, Protogerou, Athanase D. , Misra, Durga Prasanna , Agarwal, Vikas , Teji, Jagjit S. , Al-Maini, Mustafa , Dhanjil, Surinder, Nicolaides, Andrew , Rathore, Vijay , Fatemi, Mostafa , Krishnan, Pudukode R., Frence, Nagy, Naidu, Subbaram, Nagy, F. , Tsoulfas, George , Protogerou, Athanasios , Misra, Durga Prasanna , Agarwal, Vikas , Nicolaides, Andrew , Alizad, Azra , Fatemi, Mostafa , Ferenc, Nagy , Agarwal, Sushant , Suri, Jasjit S. , Pathak, Rajesh, Faa, Gavino , Mavrogeni, Sophie , Kitas, George D. , Sharma, Aditya , Alizad, Azra , Frence, Nagy, Ruzsa, Zoltán , Gupta, Archna , Kalra, Mannudeep K.

Mayo Clinic

Diagnostics | August 4, 2021 | Volume: 11 | Issue: 8 | Pages: 1405

10.3390/diagnostics11081405 | PMID 34441340 Get It

Background: COVID-19 lung segmentation using Computed Tomography (CT) scans is important for the diagnosis of lung severity. The process of automated lung segmentation is challenging due to (a) CT radiation dosage and (b) ground-glass opacities caused by COVID-19. The lung segmentation methodologies proposed in 2020 were semi- or automated but not reliable, accurate, and user-friendly. The proposed study presents a COVID Lung Image Analysis System (COVLIAS 1.0, AtheroPoint™, Roseville, CA, USA) consisting of hybrid deep learning (HDL) models for lung segmentation. Methodology: The COVLIAS 1.0 consists of three methods based on solo deep learning (SDL) or hybrid deep learning (HDL). SegNet is proposed in the SDL category while VGG-SegNet and ResNet-SegNet are designed under the HDL paradigm. The three proposed AI approaches were benchmarked against the National Institute of Health (NIH)-based conventional segmentation model using fuzzy-connectedness. A cross-validation protocol with a 40:60 ratio between training and testing was designed, with 10% validation data. The ground truth (GT) was manually traced by a radiologist trained personnel. For performance evaluation, nine different criteria were selected to perform the evaluation of SDL or HDL lung segmentation regions and lungs long axis against GT. Results: Using the database of 5000 chest CT images (from 72 patients), COVLIAS 1.0 yielded AUC of ~0.96, ~0.97, ~0.98, and ~0.96 (p-value < 0.001), respectively within 5% range of GT area, for SegNet, VGG-SegNet, ResNet-SegNet, and NIH. The mean Figure of Merit using four models (left and right lung) was above 94%. On benchmarking against the National Institute of Health (NIH) segmentation method, the proposed model demonstrated a 58% and 44% improvement in ResNet-SegNet, 52% and 36% improvement in VGG-SegNet for lung area, and lung long axis, respectively. The PE statistics performance was in the following order: ResNet-SegNet > VGG-SegNet > NIH > SegNet. The HDL runs in <1 s on test data per image. Conclusions: The COVLIAS 1.0 system can be applied in real-time for radiology-based clinical settings.
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases
Begna, Kebede H. , Kittur, Jaya, Yui, Jennifer , Gangat, Naseema , Patnaik, Mrinal M. , Al‐Kali, Aref , Elliott, Michelle A. , Litzow, Mark R. , Hook, C. Christopher , Wolanskyj, Alexandra P. , Howard, Matthew T., Hanson, Curtis A. , Pardanani, Animesh , Tefferi, Ayalew , Hook, Christopher C., Pardanani, Animesh , Tefferi, Ayalew , Wolanskyj-Spinner, Alexandra P , Hogan, William J. , Ketterling, Rhett P.

Mayo Clinic

British Journal of Haematology | August 4, 2021 | Volume: 195 | Issue: 3 | Pages: 413-416

10.1111/bjh.17742 | PMID 34346084 Get It

SummaryInstitutional database search (1999–2020) for acute myeloid leukaemia (AML) identified 109 cases of myeloid sarcoma (MS), of which 19 were isolated and presented de novo. The latter displayed longer survival (median 78 months), compared to MS with synchronous intramedullary AML (n = 32; median 16 months) and de novo AML without MS (n = 729; median 22 months; P = 0·13). However, the difference in survival was no longer apparent after accounting for bone marrow cytogenetic risk status (P = 0·67). Treatment‐induced MS tumour resolution was not affected by the presence of intramedullary disease (P = 0·61). The current study clarifies the prognosis of de novo isolated MS, in the context of AML.
Unlocking loxP to Track Genome Editing In Vivo
Gendron, William A.C. , Rubin, Jeffrey D. , Hansen, Michael J. , Nace, Rebecca A., Simone, Brandon W. , Ekker, Stephen C. , Barry, Michael A. , Ekker, Stephen C , Barry, Michael A

Mayo Clinic

Genes | August 4, 2021 | Volume: 12 | Issue: 8 | Pages: 1204

10.3390/genes12081204 | PMID 34440379 Get It

The development of CRISPR-associated proteins, such as Cas9, has led to increased accessibility and ease of use in genome editing. However, additional tools are needed to quantify and identify successful genome editing events in living animals. We developed a method to rapidly quantify and monitor gene editing activity non-invasively in living animals that also facilitates confocal microscopy and nucleotide level analyses. Here we report a new CRISPR “fingerprinting” approach to activating luciferase and fluorescent proteins in mice as a function of gene editing. This system is based on experience with our prior cre recombinase (cre)-detector system and is designed for Cas editors able to target loxP including gRNAs for SaCas9 and ErCas12a. These CRISPRs cut specifically within loxP, an approach that is a departure from previous gene editing in vivo activity detection techniques that targeted adjacent stop sequences. In this sensor paradigm, CRISPR activity was monitored non-invasively in living cre reporter mice (FVB.129S6(B6)-Gt(ROSA)26Sortm1(Luc)Kael/J and Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J, which will be referred to as LSL-luciferase and mT/mG throughout the paper) after intramuscular or intravenous hydrodynamic plasmid injections, demonstrating utility in two diverse organ systems. The same genome-editing event was examined at the cellular level in specific tissues by confocal microscopy to determine the identity and frequency of successfully genome-edited cells. Further, SaCas9 induced targeted editing at efficiencies that were comparable to cre, demonstrating high effective delivery and activity in a whole animal. This work establishes genome editing tools and models to track CRISPR editing in vivo non-invasively and to fingerprint the identity of targeted cells. This approach also enables similar utility for any of the thousands of previously generated loxP animal models.
Prognostic Value of Isolated TERT Promoter Mutation in Grade 2 and 3 IDH-Wildtype Astrocytomas
Richardson, Timothy E. , Hatanpaa, Kimmo J. , Walker, Jamie M. , Raghunathan, Aditya , Abdullah, Kalil G

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | August 3, 2021 | Volume: 80 | Issue: 9 | Pages: 885-886

10.1093/jnen/nlab067 | PMID 34343326 Get It

CERTAIN Program: Logic Model for System Level Planning and Evaluation of Innovative Education Delivery and Dissemination
Sun, Yuqiang , Li, Heyi , Tekin, Aysun, Bogojevic, Marija , Heise, Katherine J., Niven, Alexander C., Flurin, Laure , Kashyap, Rahul , Finch, A.J. , Niven, Alexander, Gajic, Ognjen , Dong, Yue

Mayo Clinic

No container title available | August 3, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-708566/v1 Get It

Abstract Background CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness and iNjury) has been shown to improve critical care process and patient outcomes in international ICUs with variable resources. Methods CERTAIN education program derived from this approach is designed, promoted, and implemented following the Logic model. Through the roadmap of the Logic model, we presented a dynamic, longitudinal implementation framework that had sufficient rigor yet offers flexibility to reach the need of the existing and emerging diversified medical education projects. Results Using the Logic model, the delivery of the CERTAIN education program is optimized to deliver relevant education content in various environments. During the COVID-19 outbreak, the implementational framework demonstrated that it could serve as an excellent template for effective response to global pandemics. Conclusions The Logical model is useful as a facilitation tool for planning and evaluating innovative education delivery and dissemination. The CERTAIN program provided an example for other continuous professional education projects.
Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis
Ikezoe, Kohei , Peterson, S. , Prins, D. A., Hague, Cameron , Murphy, Darra , Ledoux, Stacey, Chu, Fanny, Xu, Feng , Cooper, Joel D. , Tanabe, Naoya , Ryerson, Christopher J. , Paré, Peter D., Coxson, Harvey O. , Colby, Thomas V. , Hogg, James C. , Vasilescu, Dragoş M. , Tanabe, Naoya , Vasilescu, Dragoş M , Hackett, Tillie‐Louise , Prins, Dante

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | August 3, 2021 | Volume: 204 | Issue: 9 | Pages: 1048-1059

10.1164/rccm.202103-0585oc | PMID 34343057 Get It

Abstract Rationale To improve disease outcomes in idiopathic pulmonary fibrosis (IPF), it is essential to understand its early pathophysiology so that it can be targeted therapeutically. Objectives Perform three-dimensional assessment of the IPF lung microstructure using stereology and multiresolution computed tomography (CT) imaging. Methods Explanted lungs from patients with IPF (n = 8) and donor control subjects (n = 8) were inflated with air and frozen. CT scans were used to assess large airways. Unbiased, systematic uniform random samples (n = 8/lung) were scanned with microCT for stereological assessment of small airways (count number, and measure airway wall and lumen area) and parenchymal fibrosis (volume fraction of tissue, alveolar surface area, and septal wall thickness). Measurements and Main Results The total number of airways on clinical CT was greater in IPF lungs than control lungs (P &lt; 0.01), owing to an increase in the wall (P &lt; 0.05) and lumen area (P &lt; 0.05) resulting in more visible airways with a lumen larger than 2 mm. In IPF tissue samples without microscopic fibrosis, assessed by the volume fraction of tissue using microCT, there was a reduction in the number of the terminal (P &lt; 0.01) and transitional (P &lt; 0.001) bronchioles, and an increase in terminal bronchiole wall area (P &lt; 0.001) compared with control lungs. In IPF tissue samples with microscopic parenchymal fibrosis, terminal bronchioles had increased airway wall thickness (P &lt; 0.05) and dilated airway lumens (P &lt; 0.001) leading to honeycomb cyst formations. Conclusions This study has important implications for the current thinking on how the lung tissue is remodeled in IPF and highlights small airways as a potential target to modify IPF outcomes.
Prevention of Allergic-like Reactions at Repeat CT: Steroid Pretreatment versus Contrast Material Substitution
McDonald, Jennifer S. , Larson, Nicholas B. , Kolbe, Amy B. , Schmitz, John J. , Maddox, Daniel E. , Hartman, Robert P. , Kallmes, David F. , McDonald, Robert J. , Hunt, Christopher H , Schmitz, John J , Maddox, Daniel E , Hartman, Robert P , Kallmes, David F , McDonald, Robert J , Larson, Nicholas B , Hunt, Christopher H.

Mayo Clinic

Radiology | August 3, 2021 | Volume: 301 | Issue: 1 | Pages: 133-140

10.1148/radiol.2021210490 | PMID 34342504 Get It

Pancreas-specific CHRM3 activation causes pancreatitis in mice
Wan, Jianhua , Wang, Jiale , Wagner, Larry E. , Wang, Oliver H., Gui, Fu , Chen, Jiaxiang , Zhu, Xiaohui , Haddock, Ashley , Edenfield, Brandy , Haight, Brian, Yule, David I. , Bi, Yan , Ji, Baoan , Haddock, Ashley N, Edenfield, Brandy H, Wang, Jiale , Gui, Fu , Haight, Brian, Mukhopadhyay, Debabrata , Wang, Ying , Wan, Jianhua

Mayo Clinic

JCI Insight | August 3, 2021 | Volume: 6 | Issue: 17 | Pages: No page available

10.1172/jci.insight.132585 | PMID 34314386 Get It

Hyperstimulation of the cholecystokinin 1 receptor (CCK1R), a G protein–coupled receptor (GPCR), in pancreatic acinar cells is commonly used to induce pancreatitis in rodents. Human pancreatic acinar cells lack CCK1R but express cholinergic receptor muscarinic 3 (M3R), another GPCR. To test whether M3R activation is involved in pancreatitis, a mutant M3R was conditionally expressed in pancreatic acinar cells in mice. This mutant receptor loses responsiveness to its native ligand, acetylcholine, but can be activated by an inert small molecule, clozapine- N -oxide (CNO). Intracellular calcium and amylase were elicited by CNO in pancreatic acinar cells isolated from mutant M3R mice but not WT mice. Similarly, acute pancreatitis (AP) could be induced by a single injection of CNO in the transgenic mice but not WT mice. Compared with the cerulein-induced AP, CNO caused more widespread acinar cell death and inflammation. Furthermore, chronic pancreatitis developed at 4 weeks after 3 episodes of CNO-induced AP. In contrast, in mice with 3 recurrent episodes of cerulein-included AP, pancreas histology was restored in 4 weeks. Furthermore, the M3R antagonist ameliorated the severity of cerulein-induced AP in WT mice. We conclude that M3R activation can cause the pathogenesis of pancreatitis. This model may provide an alternative approach for pancreatitis research.